Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
The novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intr...
Main Authors: | Shikha G. Khosla MD, Eric S. Nylen MD, Rahul Khosla MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709620984603 |
Similar Items
-
Sertraline-Induced Hypoglycemia in Type 2 Diabetes Patients
by: David Ni, MD, et al.
Published: (2016-01-01) -
Rhabdomyolysis as a manifestation of a severe case of COVID-19: A case report
by: Rola Husain, MB, BCh, BAO, et al.
Published: (2020-09-01) -
Pediatric COVID-19 Associated Rhabdomyolysis
by: Parisa Armanpoor, et al.
Published: (2021-09-01) -
SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
by: Josef Finsterer MD, PhD
Published: (2021-02-01) -
Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine
by: Ajmera KM
Published: (2021-09-01)